mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.07 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.08 |
0.07 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.07 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |